Literature DB >> 16550369

Serum levels of seven cytokines in premature ventilated newborns: correlations with old and new forms of bronchopulmonary dysplasia.

Giovanni Vento1, Ettore Capoluongo, Piero G Matassa, Paola Concolino, Valentina Vendettuoli, Cinzia Vaccarella, Simona Frezza, Cecilia Zuppi, Costantino Romagnoli, Franco Ameglio.   

Abstract

OBJECTIVE: In addition to the previous classification of chronic lung disease (CLD) O2 dependency at 36 weeks of postmenstrual age, a new definition of CLD has recently been proposed: new bronchopulmonary-dysplasia (BPD). This uses total duration of O2 supplementation and positive pressure requirements to delineate three degrees of severity (mild, moderate, and severe) according to the respiratory status at 36 weeks postmenstrual age. We analyzed the balance of serum proinflammatory and profibrotic/angiogenic cytokine concentrations in relation to CLD and the new BPD definition. DESIGN AND
SETTING: Descriptive study in a third-level neonatal ICU. PATIENTS: Thirty-one preterm neonates with a gestational age of 24-29 weeks were studied to evaluate their serum cytokine concentration; they were previously enrolled in a randomized clinical trial to compare the effects of high-frequency oscillatory ventilation vs. intermittent mandatory ventilation in terms of pulmonary mechanics and lung cytokines. Serum samples were collected on days 1, 3, and 5 after birth until extubation to detect the levels of three proinflammatory cytokines plus four profibrotic/angiogenic cytokines, and correlations were examined to old CLD and new BPD. Ventilation treatments were distributed homogeneously between the groups and did not interfere with the results presented here. RESULTS AND
CONCLUSIONS: Old CLD development, mainly corresponding to the moderate/severe forms of new BPD, was associated with increased proinflammatory and profibrotic/angiogenic cytokines, while mild forms of new BPD were characterized only by increases in profibrotic/angiogenic cytokines, suggesting a different balance of two pathogenic mechanisms in different phases of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16550369     DOI: 10.1007/s00134-006-0138-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  24 in total

Review 1.  Growth factors, postnatal lung growth and bronchopulmonary dysplasia.

Authors:  Robert P Jankov; A Keith Tanswell
Journal:  Paediatr Respir Rev       Date:  2004       Impact factor: 2.726

2.  Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia.

Authors:  K Tullus; G W Noack; L G Burman; R Nilsson; B Wretlind; A Brauner
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

3.  Neonatal chronic lung disease in extremely immature baboons.

Authors:  J J Coalson; V T Winter; T Siler-Khodr; B A Yoder
Journal:  Am J Respir Crit Care Med       Date:  1999-10       Impact factor: 21.405

4.  Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome.

Authors:  Michael W Beresford; Nigel J Shaw
Journal:  Pediatr Res       Date:  2002-12       Impact factor: 3.756

5.  Chronic lung injury in preterm lambs. Disordered respiratory tract development.

Authors:  K H Albertine; G P Jones; B C Starcher; J F Bohnsack; P L Davis; S C Cho; D P Carlton; R D Bland
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

Review 6.  Cytokines and bullous pemphigoid.

Authors:  L D'Auria; P Cordiali Fei; F Ameglio
Journal:  Eur Cytokine Netw       Date:  1999-06       Impact factor: 2.737

7.  Chronic lung disease of prematurity and intrauterine growth retardation: a population-based study.

Authors:  Mithilesh K Lal; Bradley N Manktelow; Elizabeth S Draper; David J Field
Journal:  Pediatrics       Date:  2003-03       Impact factor: 7.124

8.  CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia.

Authors:  R John Baier; Abdul Majid; Haroon Parupia; John Loggins; Thomas E Kruger
Journal:  Pediatr Pulmonol       Date:  2004-02

9.  Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin.

Authors:  Eloisa Gitto; Russel J Reiter; Aurelio Amodio; Carmelo Romeo; Elisabetta Cuzzocrea; Giuseppe Sabatino; Giuseppe Buonocore; Vincenzo Cordaro; Giuseppe Trimarchi; Ignazio Barberi
Journal:  J Pineal Res       Date:  2004-05       Impact factor: 13.007

Review 10.  Year in review in intensive care medicine, 2004. I. Respiratory failure, infection, and sepsis.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2004-12-18       Impact factor: 17.440

View more
  19 in total

Review 1.  Pathogenesis and treatment of bronchopulmonary dysplasia.

Authors:  Jason Gien; John P Kinsella
Journal:  Curr Opin Pediatr       Date:  2011-06       Impact factor: 2.856

2.  Clara cell secretory protein (CC16) as a peripheral blood biomarker of lung injury in ventilated preterm neonates.

Authors:  Kosmas Sarafidis; Theodora Stathopoulou; Elisavet Diamanti; Vasiliki Soubasi; Charalambos Agakidis; Aikaterini Balaska; Vasiliki Drossou
Journal:  Eur J Pediatr       Date:  2008-06-03       Impact factor: 3.183

Review 3.  Prevention and management of bronchopulmonary dysplasia: Lessons learned from the neonatal research network.

Authors:  Kathleen A Kennedy; C Michael Cotten; Kristi L Watterberg; Waldemar A Carlo
Journal:  Semin Perinatol       Date:  2016-10       Impact factor: 3.300

Review 4.  Mesenchymal stem cells in the pathogenesis and treatment of bronchopulmonary dysplasia: a clinical review.

Authors:  Ann A Simones; Daniel J Beisang; Angela Panoskaltsis-Mortari; Kari D Roberts
Journal:  Pediatr Res       Date:  2017-10-25       Impact factor: 3.756

5.  Umbilical cord serum interleukin-6, C-reactive protein, and myeloperoxidase concentrations at birth and association with neonatal morbidities and long-term neurodevelopmental outcomes.

Authors:  Yoram Sorokin; Roberto Romero; Lisa Mele; Jay D Iams; Alan M Peaceman; Kenneth J Leveno; Margaret Harper; Steve N Caritis; Brian M Mercer; John M Thorp; Mary Jo O'Sullivan; Susan M Ramin; Marshall W Carpenter; Dwight J Rouse; Baha Sibai
Journal:  Am J Perinatol       Date:  2013-12-11       Impact factor: 1.862

6.  Transforming growth factor-beta modulates the expression of nitric oxide signaling enzymes in the injured developing lung and in vascular smooth muscle cells.

Authors:  Patricia R Bachiller; Hidehiko Nakanishi; Jesse D Roberts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-18       Impact factor: 5.464

Review 7.  Bronchopulmonary dysplasia.

Authors:  Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe
Journal:  Nat Rev Dis Primers       Date:  2019-11-14       Impact factor: 52.329

Review 8.  Biomarkers, Early Diagnosis, and Clinical Predictors of Bronchopulmonary Dysplasia.

Authors:  Charitharth Vivek Lal; Namasivayam Ambalavanan
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

9.  Prior hypoxia prevents downregulation of ACE-2 by hyperoxia in fetal human lung fibroblasts.

Authors:  Tarek L Mohamed; Hang T Nguyen; Amal Abdul-Hafez; Vinh X Dang; MyTrang T Dang; Ira H Gewolb; Bruce D Uhal
Journal:  Exp Lung Res       Date:  2016-04       Impact factor: 2.459

10.  Mannose-binding lectin polymorphisms and pulmonary outcome in premature neonates: a pilot study.

Authors:  Ettore Capoluongo; Giovanni Vento; Sandro Rocchetti; Emiliano Giardina; Paola Concolino; Cecilia Sinibaldi; Concetta Santonocito; Valentina Vendettuoli; Milena Tana; Chiara Tirone; Cecilia Zuppi; Costantino Romagnoli; Giuseppe Novelli; Bruno Giardina; Franco Ameglio
Journal:  Intensive Care Med       Date:  2007-07-26       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.